Primmune Therapeutics
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Jlabs 3210 San Diego, San Diego, Califor...Phone Number
(858) 205-2281Website
www.primmunerx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Primmune Therapeutics
Primmune Therapeutics is a clinical-stage biotechnology company headquartered in San Diego, USA, focused on developing orally administered small-molecule immunotherapies that harness innate immunity to improve cancer and viral disease treatment. Its lead investigational candidate, PRTX007, is designed to activate key immune pathways without triggering broad inflammatory responses, aiming to enhance antitumor immunity and complement existing therapies while advancing through clinical studies.Explore more
Primmune Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Primmune Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Primmune Therapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Primmune Therapeutics
Primmune Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Primmune Therapeutics has new funding data
Check out if Primmune Therapeutics is spiking on competitors!
Product Launch: Get notified when Primmune Therapeutics launches new products
Check if Primmune Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Primmune Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Primmune Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Primmune Therapeutics
Compare insights from companies similar to Primmune Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Primmune Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Primmune Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Primmune Therapeutics.
Primmune Therapeutics financials insights
Gather financial insights about Primmune Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Angel/Seed
$7M
2021
Series A
$31.4M
2026
Series B
$23.3M
Primmune Therapeutics Tech Stack
A closer look at the technologies used by Primmune Therapeutics
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Executive Move
Executive Moves, Board of Directors
New Hire
Executive Move
Executive Moves, New Hire
Funding
Funding
Executive Move
Board of Directors
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Primmune Therapeutics
Sign Up For FreeTo access detailed company insights
Primmune Therapeutics is a clinical-stage biotechnology company headquartered in San Diego, USA, focused on developing orally administered small-molecule immunotherapies that harness innate immunity to improve cancer and viral disease treatment. Its lead investigational candidate, PRTX007, is designed to activate key immune pathways without trigger... Read More
